EpiPen and EpiPen Jr. Life-Threatening Failures

In March 2017, EpiPen and EpiPen Jr. auto injectors were recalled due to a potential failure to activate.

EpiPen’s are used to treat allergic emergencies, also known as anaphylaxis. Anaphylaxis is an acute reaction to an allergen that can be serious and even fatal.

On September 5th, 2017 the FDA said EpiPen manufacturer (Meridian Medical Technologies, Inc. a Pfizer Company) a letter addressed to the company’s President and General Manager stating the following: 

“Among other things, you manufacture two epinephrine auto-injectors at your facility, EpiPen and EpiPen Jr., (collectively, EpiPen products). These products are intended to deliver a lifesaving drug (epinephrine) during emergency treatment of serious allergic reactions, including anaphylaxis. If your auto-injectors do not operate as expected and deliver the intended amount of epinephrine drug when deployed in emergencies, patients can die or suffer serious illness. You failed to thoroughly investigate multiple serious component and product failures for your EpiPen products, including failures associated with patient deaths and severe illness. You also failed to expand the scope of your investigations into these serious and life-threatening failures or take appropriate corrective actions, until FDA’s inspection.”

Read the complete letter here.

Meridian’s reported failures have put countless men, women, and children at risk for serious injury and even death. If you or a loved one suffered adverse effects because your EpiPen failed to activate contact us today.